Correspondence re: A. Lipton et al., serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002

Clinical Cancer Research

Volumn 9, Issue 6, 2003, Pages 2384-2386

  Dovio, Andrea ^a   Sartori, Maria Luisa ^a   Angeli, Alberto ^a   Lipton, Allan ^b   Ali, Suhail ^b   Leitzel, Kim ^b   Witers, Lois ^b   Holloway, Donna ^c   Bekker, Pirow ^c   Dunstan, Colin ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MONOCLONAL ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; BLOOD LEVEL; BONE TUMOR; CANCER PATIENT; COLORECTAL CANCER; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOOD LABORATORY PRACTICE; HUMAN; LABORATORY DIAGNOSIS; LETTER; LIVER METASTASIS; LYMPHOMA; MALE; MYELOMA; NORMAL HUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SOFT TISSUE METASTASIS; VALIDATION PROCESS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; NEOPLASMS; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0038513811     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)